Richard A Erali

6PUBLICATIONS
9CO-AUTHORS
Cancer geneticsBiomaterialsMolecular targetsGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 16, 2025
The Genomic Topography of Appendiceal Cancers: Our Current Understanding, Clinical Perspectives, and Future Directions.

Daniel J Gironda, Richard A Erali, Steven D Forsythe

|May 14, 2024
ASO Author Reflections: Innovative HIPEC Organoid Models and Mucolytics: Targeted Therapeutic Use of Bromelain for Appendiceal Cancer.

Richard A Erali, Nadeem Wajih, David L Morris

|Jun 21, 2023
Comparison of survival for metastatic pancreatic cancer patients treated with CPI-613 versus resected borderline-resectable pancreatic cancer patients.

Christopher W Mangieri, Cristian D Valenzuela, Ian B Solsky

|May 15, 2023
Pivotal Role of Genetic Counselors in the Uptake of Germline Genetic Testing in Non-Metastatic Breast Cancer and the Impact of Testing on Surgical Decision Making.

Richard A Erali, Tracey Pu, Thuy M Vu

|Oct 26, 2022
Impact of myometrium invasion on survival outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC).

Christopher W Mangieri, Cristian D Valenzuela, Ian B Solsky

|Jul 02, 2021
Organoid Platform in Preclinical Investigation of Personalized Immunotherapy Efficacy in Appendiceal Cancer: Feasibility Study.

Steven D Forsythe, Richard A Erali, Shyama Sasikumar

Pageof 1

Frequent Collaborators

2 joint publications

Steven D Forsythe

2 joint publications

Lance D Miller

2 joint publications

Edward A Levine

1 joint publications

Shyama Sasikumar